Numeral Limited

ZAc 25.00As of Sun 8 Nov 2026, 12:00 UTC

JSE:XIIHealthcare

Country South Africa

PE (Fwd) —

TSR 10Y CAGR 46.01%

Div yield —

ROE (5.48%)

Drug Manufacturers (Specialty & Generic)

Beta (5Y) —

PE TTM —

TSR TTM 124900.00%

Mkt cap R 310.6M

ROIC 37.53%

SE Grade™

Value

Quality

Moat

1Y Price

Reference

ZAc 27

9.65%

28.96%

Price below Reference Value

TTM

FYE 28 Feb USD

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

2.110

Revenue$M

—

◌—

0.083

0.975

2.200

2.985

414.83%

—

Revenue growth%

—

1074.48

125.68

35.67

600.08

—

Gross margin%

—

◌—

79.59

78.38

77.77

78.98

—

100

94.77

Operating margin%

—

25.82

79.27

77.28

77.77

77.28

—

100

(1.96)

Net margin%

—

26.04

15.59

3.63

(7.94)

15.59

—

P/E ratio (avg)x

—

0.032

0.084

0.624

—

0.084

—

11.64

EV/EBITx

—

4.855

4.552

2.316

10.30

4.552

—

(6.33)

FCF yield (avg)%

—

(10831.36)

(2377.46)

(3505.94)

(236.82)

(5.73)

(2941.70)

—

(56.44)

FCF margin%

—

(19.78)

(46.06)

(5.37)

(36.09)

(19.78)

—

28.84

FCF / Net incomex

—

0.981

(0.759)

(2.954)

(1.478)

—

(1.119)

—

37.53

ROIC%

—

37.62

38.70

41.91

38.16

—

(5.48)

Return on equity%

—

60.74

11.48

(34.11)

36.11

—

(0.69)

Return on assets%

—

(30106.27)

66.91

3.20

1.46

(3.79)

2.33

—

100

—

EPS$

—

(39.19%)

—

EPS growth%

—

114.64

(29.68)

(47.41)

(396.29)

(29.68)

—

Bookvalue per sh$

—

(0.01)

—

15.20%

—

FCF per share$

—

Dividend per sh$

—

Div yield (avg)%

—

Payout ratio%

—

1.242

Shares (diluted)B

—

0.077

0.124

1.242

◌1.242

152.97%

—

Buyback yield%

—

(61.89)

(900.00)

—

◌—

(61.89)

—

6.286

D/E ratiox

—

(0.807)

(0.705)

5.722

5.570

8.040

2.433

—

23.27

Enterprise value$M

—

0.340

0.104

3.517

3.938

23.92

126.33%

—

4.685

LT debt$M

—

3.673

4.132

5.062

12.50%

—

Peers (US$7.464M)

Cap (US$)

AfroCentric Investment…

34.20M

—

Cilo Cybin Holdings…

15.70M

—

Labat Africa Limited

2.268M

0.277x

Qianhai Health…

7.349M

14.37x

Capital

TTM

10Y

Leveragex

2.039

4.176

EBIT/Intx

—

2.610

Own earn%

—

Sh yield%

—

(61.89)

Owners

Insiders/Inst%

6.44

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

3/4

Revenue growth years

—

EPS growth years

1/3

Dividend streakyrs

Op margin range%

26–79

$1 testx

—

Incr. ROIC%

—

Numeral Limited, an investment holding company, engages in biotech, health and pharmaceutical, and financial businesses in Mauritius. It operates through Biotechnology and Healthcare Services, Financial Services, Investment Activities and Asset Management segments.

Growth vs revenue

Latest

Trend

2Y CAGR

Rel growth

Revenue

$2.200M

414.83%

1.00×

Cost of revenue

$0.476M

Operating expenses

$0.024M

Asset mix

Trend

Other

85.96%

Goodwill & intangibles

9.18%

Cash and investments

4.86%

Reinvestment returns

No breakdown available